M. Yarchoan

机构：Sidney Kimmel Cancer Center, Sidney Kimmel Comprehensive Cancer Center

发表论文 5 篇 · 总被引 352 次 · h-index 2

代表论文

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma (2024 · Annals of Oncology · 被引 343)
83P Impact of viral aetiology in the phase III HIMALAYA study of tremelimumab (T) plus durvalumab (D) in unresectable hepatocellular carcinoma (uHCC) (2022 · Annals of Oncology · 被引 8)
67O Outcomes in the Asian subgroup of the phase III HIMALAYA study of tremelimumab (T) plus durvalumab (D) in unresectable hepatocellular carcinoma (uHCC) (2022 · Annals of Oncology · 被引 2)
208P Neoadjuvant immunotherapy in hepatocellular carcinoma: Patterns of recurrence treatment sequencing and long-term survival outcomes from the NeoHCC cohort (2026 · Annals of Oncology)
288eTiP A multicenter, open-label, first-in-human study of TYRA-430 in advanced hepatocellular carcinoma and other solid tumors with activating FGF/FGFR pathway aberrations (SURF431) (2025 · Annals of Oncology)